Veterinarians across the country are collecting hair, nail and fluid samples from more than 3,000 purebred golden retrievers for the $32 million Golden Retriever Lifetime Study in which researchers hope to gain insight into cancer and other diseases that afflict dogs and people. Owners of participating animals also submit information about their dogs' daily lives and environments, and veterinarian Sharon Albright says the owners are a "passionate cohort."
Photographer Julius Motal attended a fundraiser for cats one night in July and subsequently "rode the wave from one cat extravaganza to the next." The experience led to a documentary titled "Cat People."
Many young women who undergo treatment for breast cancer subsequently experience arm swelling and loss of function despite falling rates of axillary node dissection, according to a study presented at the San Antonio Breast Cancer Symposium. More preoperative counseling and postoperative interventions may be beneficial, researcher Anne Kuijer said.
Researchers analyzed data from the National Health and Nutrition Examination Survey from 2005 to 2014 and found that the overall prevalence of diabetes and undiagnosed diabetes among US veterans was 20.5% and 3.4%, respectively, in 2013 to 2014. The findings in the CDC's Preventing Chronic Disease revealed that diabetes prevalence increased from 15.5% in 2005 to 2006 to 20.5% in 2013 to 2014.
A study in Diabetes Care showed that higher levels of certain advanced glycation end products and lower levels of the oxidation product methionine sulfoxide were associated with an increased risk for cardiovascular disease among adults with type 2 diabetes. Researchers used a cohort of 716 patients with and without diabetes from the Veterans Affairs Diabetes Trial and the ACCORD study and found that those with prior CVD had higher carboxymethyl lysine, glyoxal hydroimidazolone and 3-deoxyglucosone hydroimidazolone, compared with those without prior CVD.
Type 2 diabetes patients who received GLP-1 receptor agonists experienced a 10% reduction in their risk for a combination of stroke, heart attack or death from heart disease, a 13% reduction in heart disease mortality risk and a 12% reduced risk for all-cause mortality, compared with those on placebo, according to a study in The Lancet Diabetes & Endocrinology. UK researchers evaluated data from four trials and found no significant differences in terms of severe hypoglycemia, pancreatic cancer and pancreatitis between the groups.
HealthCare.gov enrollments were 17% higher this year compared with the same time period last year, according to data shared by HHS this week, and many of those signing up are new enrollees. Although the shortened enrollment window ending today means the total will likely come in well under last year's enrollment, observers have been surprised by this year's pace given reduced advertising and navigator support.
AHIP and other stakeholders wrote a letter to state insurance commissioners arguing that an executive order signed in October that sought to relax Affordable Care Act rules and expand access to leaner health plans could further destabilize markets and raise premiums, particularly for those with pre-existing conditions. The groups encouraged states to reinstate duration limits on short-term plans if federal regulations ultimately allow longer coverage periods, and the letter called on regulators to protect consumers from other consequences of a change in standards.
Republican leaders' effort to pass a $1.5 trillion compromise tax bill has been complicated by a declaration from Sen. Marco Rubio, R-Fla., that he will oppose the legislation unless the child tax credit for low-income families is expanded, while a number of other Republican senators said they are still undecided and two others have missed votes this week because of health issues. Rubio's possible defection threatens Republicans' slim majority on the tax plan, which targets the Affordable Care Act mandate that most Americans buy health insurance or face penalty.
Researchers found no significant link between proton pump inhibitor exposure and increased odds of dementia or Alzheimer's disease among patients with newly diagnosed dementia. The findings in the Journal of the American Geriatrics Society, based on data involving 3,484 individuals ages 65 and older, also found that duration of PPI use wasn't tied to dementia risk.
- Page 1